Pfizer Inc. [PFE] stock prices are down -0.12% to $25.39 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PFE shares have lost -3.61% over the last week, with a monthly amount drifted -8.11%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Pfizer Inc. [NYSE: PFE] stock has seen the most recent analyst activity on March 22, 2024, when Argus downgraded its rating to a Hold. Previously, Guggenheim started tracking the stock with Buy rating on February 23, 2024, and set its price target to $36. On January 04, 2024, downgrade downgraded it’s rating to Market Perform but maintained its price target of $32 on the stock. Jefferies upgraded its rating to a Buy and raised its price target to $39 on October 16, 2023. JP Morgan reiterated a Neutral rating for this stock on July 17, 2023, and downed its price target to $41. In a note dated July 14, 2023, HSBC Securities initiated an Buy rating and provided a target price of $50 on this stock.
The stock price of Pfizer Inc. [PFE] has been fluctuating between $25.26 and $41.33 over the past year. Currently, Wall Street analysts expect the stock to reach $57.55 within the next 12 months. Pfizer Inc. [NYSE: PFE] shares were valued at $25.39 at the most recent close of the market. An investor can expect a potential return of 126.66% based on the average PFE price forecast.
Analyzing the PFE fundamentals
The Pfizer Inc. [NYSE:PFE] reported sales of 58.50B for trailing twelve months, representing a drop of -41.34%. Gross Profit Margin for this corporation currently stands at 0.49% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.02 and Total Capital is 0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.81.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 25.26 points at the first support level, and at 25.13 for the second support level. However, for the 1st resistance point, the stock is sitting at 25.49, and for the 2nd resistance point, it is at 25.59.
Ratios To Look Out For
It’s worth pointing out that Pfizer Inc. [NYSE:PFE]’s Current Ratio is 0.91. As well, the Quick Ratio is 0.69, while the Cash Ratio is 0.06. Considering the valuation of this stock, the price to sales ratio is 2.45, the price to book ratio is 1.61 and price to earnings (TTM) ratio is 70.65.
Transactions by insiders
Recent insider trading involved Gottlieb Scott, Director, that happened on Dec 15 ’23 when 3000.0 shares were purchased. Director, Gottlieb Scott completed a deal on May 08 ’23 to buy 1000.0 shares. Meanwhile, Director Gottlieb Scott bought 1000.0 shares on May 05 ’23.
